#RobinWilliams radiated in the spotlight ☀️ His tragic passing was a loss felt by all, and it brought an increased focus on #LewyBodyDementia. Learn about his battle with this terrible disease: https://t.co/EFJvlt4cG5
#lewybodydementiaawareness#neurology https://t.co/Dbcgy0qOdy
It takes a village to care for loved ones suffering from LBD. We created this directory to make it easier for patients and their families to connect with a care center near them and build a supportive care team 💙
https://t.co/CbInevlh8j #LBDtest https://t.co/ACWeND6I8Q
Did you know that of the 60 million people aged 65+ in the US, about 12 million show early cognitive impairment symptoms?
🔹 1/3 of these 12 million people will improve over time
🔹 1/3 will progress quickly to dementia
🔹 And the rest will remain mildly.. https://t.co/2RoNUNPGd8
Amprion's Prion Detection Science sheds a new light on the complexity of Alzheimer's. We’re racing towards personalized medicine to end neurodegenerative disease.
https://t.co/nIWErqqUgw
#Amprionme#biomarkertest#parkinsonsdisease#lewybodydementia https://t.co/nIWErqqUgw
Exciting News! Amprion announces the launch of its SYNTap Biomarker Test.
"...Traditionally, patients are diagnosed based on clinical symptoms, which means their disease is relatively advanced," said Amprion Co-founder and Chief Scientific Officer Claudio Soto, Ph.D.
Walking into the week amped up & ready to make new #scientificbreakthroughs!
At Amprion, we believe #science is a team sport, & the more we collaborate & encourage each other, the more advancements we will be able to make!🌟
Meet our amazing team: https://t.co/hFBroBiXsz
A heartbreaking & powerful letter by #RobinWilliams' widow, #SusanSchneiderWilliams about his battle with #LewyBodyDementia. Stories like this are why we do the work we do & why an accurate diagnosis is vital in the fight against neurodegenerative diseases
https://t.co/Psci7XE819